Suppr超能文献

局灶性结节性增生和肝细胞腺瘤的图片。

Pictures of focal nodular hyperplasia and hepatocellular adenomas.

作者信息

Sempoux Christine, Balabaud Charles, Bioulac-Sage Paulette

机构信息

Christine Sempoux, Service d'Anatomie Pathologique, Cliniques universitaires Saint Luc, Université catholique de Louvain, 1200 Brussels, Belgium.

出版信息

World J Hepatol. 2014 Aug 27;6(8):580-95. doi: 10.4254/wjh.v6.i8.580.

Abstract

This practical atlas aims to help liver and non liver pathologists to recognize benign hepatocellular nodules on resected specimen. Macroscopic and microscopic views together with immunohistochemical stains illustrate typical and atypical aspects of focal nodular hyperplasia and of hepatocellular adenoma, including hepatocellular adenomas subtypes with references to clinical and imaging data. Each step is important to make a correct diagnosis. The specimen including the nodule and the non-tumoral liver should be sliced, photographed and all different looking areas adequately sampled for paraffin inclusion. Routine histology includes HE, trichrome and cytokeratin 7. Immunohistochemistry includes glutamine synthase and according to the above results additional markers such as liver fatty acid binding protein, C reactive protein and beta catenin may be realized to differentiate focal nodular hyperplasia from hepatocellular adenoma subtypes. Clues for differential diagnosis and pitfalls are explained and illustrated.

摘要

这本实用图谱旨在帮助肝脏病理学家和非肝脏病理学家识别切除标本上的良性肝细胞结节。宏观和微观视图以及免疫组化染色展示了局灶性结节性增生和肝细胞腺瘤的典型及非典型特征,包括肝细胞腺瘤的亚型,并参考了临床和影像学数据。每一步对于做出正确诊断都很重要。应将包含结节和非肿瘤性肝脏的标本切片、拍照,并对所有外观不同的区域进行充分取样以用于石蜡包埋。常规组织学检查包括苏木精-伊红染色(HE)、三色染色和细胞角蛋白7染色。免疫组化包括谷氨酰胺合成酶染色,根据上述结果,可采用其他标志物如肝脂肪酸结合蛋白、C反应蛋白和β-连环蛋白来区分局灶性结节性增生与肝细胞腺瘤亚型。文中解释并举例说明了鉴别诊断的线索和陷阱。

相似文献

1
Pictures of focal nodular hyperplasia and hepatocellular adenomas.
World J Hepatol. 2014 Aug 27;6(8):580-95. doi: 10.4254/wjh.v6.i8.580.
2
Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.
Clin Mol Hepatol. 2016 Jun;22(2):199-211. doi: 10.3350/cmh.2016.0101. Epub 2016 May 18.
4
Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
Hum Pathol. 2009 May;40(5):726-34. doi: 10.1016/j.humpath.2008.10.018. Epub 2009 Jan 20.
6
Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
Semin Liver Dis. 2011 Feb;31(1):91-103. doi: 10.1055/s-0031-1272837. Epub 2011 Feb 22.
7
A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
Arch Pathol Lab Med. 2015 Apr;139(4):537-42. doi: 10.5858/arpa.2013-0645-OA.
8
[Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors].
Ann Pathol. 2010 Dec;30(6):439-47. doi: 10.1016/j.annpat.2010.10.005. Epub 2010 Nov 27.

引用本文的文献

1
Hepatocellular Adenoma With Hepatocyte Nuclear Factor-1 Alpha (HNF-1α) Mutation: A Case Report.
Cureus. 2024 Jul 7;16(7):e64017. doi: 10.7759/cureus.64017. eCollection 2024 Jul.
2
Hepatocellular Carcinoma in Non-Fibrotic Liver: A Narrative Review.
Diagnostics (Basel). 2023 Nov 10;13(22):3426. doi: 10.3390/diagnostics13223426.
3
Re-Recognizing the Cellular Origin of the Primary Epithelial Tumors of the Liver.
J Hepatocell Carcinoma. 2021 Dec 7;8:1537-1563. doi: 10.2147/JHC.S334935. eCollection 2021.
4
Focal nodular hyperplasia associated with a giant hepatocellular adenoma: A case report and review of literature.
World J Hepatol. 2021 Oct 27;13(10):1450-1458. doi: 10.4254/wjh.v13.i10.1450.
5
MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma.
Pathol Oncol Res. 2019 Jul;25(3):1103-1109. doi: 10.1007/s12253-018-0528-z. Epub 2018 Nov 9.
6
Hepatocellular adenoma management: advances but still a long way to go.
Hepat Oncol. 2015 Apr;2(2):171-180. doi: 10.2217/hep.14.41. Epub 2015 May 15.
7
Hepatocyte Nuclear Factor 1α-Mutated Hepatocellular Adenomas: An Atypical Presentation.
Case Rep Gastroenterol. 2017 Oct 30;11(3):637-642. doi: 10.1159/000480376. eCollection 2017 Sep-Dec.

本文引用的文献

2
Hepatocellular benign tumors-from molecular classification to personalized clinical care.
Gastroenterology. 2013 May;144(5):888-902. doi: 10.1053/j.gastro.2013.02.032. Epub 2013 Feb 26.
5
Hepatocellular adenoma subtypes: the impact of overweight and obesity.
Liver Int. 2012 Sep;32(8):1217-21. doi: 10.1111/j.1478-3231.2012.02786.x. Epub 2012 Mar 19.
6
Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.
Semin Liver Dis. 2011 Feb;31(1):91-103. doi: 10.1055/s-0031-1272837. Epub 2011 Feb 22.
7
Will the pathomolecular classification of hepatocellular adenomas improve their clinical management?
J Hepatol. 2011 Jul;55(1):8-10. doi: 10.1016/j.jhep.2011.01.016. Epub 2011 Mar 15.
8
Subtype classification of hepatocellular adenoma.
Dig Surg. 2010;27(1):39-45. doi: 10.1159/000268406. Epub 2010 Apr 1.
9
Malignant transformation of liver adenoma: an analysis of the literature.
Dig Surg. 2010;27(1):32-8. doi: 10.1159/000268405. Epub 2010 Apr 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验